Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.

Saved in:
Bibliographic Details
Title: Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
Authors: Ferguson JS; Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Suite 5233, 1685 Highland Avenue, Madison, WI, 53705, USA. jsferguson@medicine.wisc.edu., Van Wert R; Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, 300 Pasteur Dr, H3143 MC 5236, Stanford, CA, 94305, USA., Choi Y; Veracyte, Inc, 6000 Shoreline Ct, #300, South San Francisco, CA, 94080, USA., Rosenbluth MJ; Veracyte, Inc, 6000 Shoreline Ct, #300, South San Francisco, CA, 94080, USA., Smith KP; Veracyte, Inc, 6000 Shoreline Ct, #300, South San Francisco, CA, 94080, USA., Huang J; Veracyte, Inc, 6000 Shoreline Ct, #300, South San Francisco, CA, 94080, USA., Spira A; Division of Computational Biomedicine, Department of Medicine, Boston University Medical Center, 715 Albany St, Boston, MA, 02118, USA.
Source: BMC pulmonary medicine [BMC Pulm Med] 2016 May 17; Vol. 16 (1), pp. 66. Date of Electronic Publication: 2016 May 17.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2466
DOI:10.1186/s12890-016-0217-1